Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关副作用是
,但严重到足以停药
程度是罕
。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关副作用是
,但严重到足以停药
程度是罕
。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种巴
巴
激动剂,与第一代
巴
激动剂不同
是没有麦角林结构。罗匹尼罗
非麦角林结构可以说明其与
巴
D2受体有较高
结合力。
声明:以上例句、词性分均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关的副作用是常见的,但严重到足以停药的程度是罕见的。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似巴
的
巴
激动剂,
第一代
巴
激动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明
巴
D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性释放因子治疗相关的副作用是常见的,但严重到足以停药的程度是罕见的。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价受体
动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似的
动剂,与第一代
动剂不同的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与
D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关副作用是常见
,但严重到足以停药
程度是罕见
。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
匹
是一种类似多巴
多巴
激动剂,与第一代多巴
激动剂不同
是没有麦角林结构。
匹
非麦角林结构可以说明其与多巴
D2受体有较高
结合力。
声明:以上例句、词性分类均由互联网资源自动成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关的副作用是常见的,但严重到足以停药的程度是罕见的。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
尼
是一种类似多巴
的多巴
激动剂,与第一代多巴
激动剂不同的是没有麦角林结
。
尼
的非麦角林结
可以说明其与多巴
D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关的副作用的,但严重到足以停药的程度
罕
的。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价受体激动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗一种类
的
激动剂,与第一代
激动剂不同的
没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与
D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促性腺激素释放因子治疗相关副作用是常
,
严重到足以停药
程度是罕
。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动剂临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一多巴
多巴
激动剂,与第一代多巴
激动剂不同
是没有麦角林结构。罗匹尼罗
非麦角林结构可以说明其与多巴
D2受体有较高
结合力。
声明:以上例句、词性分均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
短期促腺激素释放因子治
相关
副作用是常见
,但严重到足以停
度是罕见
。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动剂临床应
。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多巴多巴
激动剂,与第一代多巴
激动剂不同
是没有麦角林结构。罗匹尼罗
非麦角林结构可以说明其与多巴
D2受体有较高
结合力。
声明:以上例句、词分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.
促性腺激素释放因子治疗相关的副作用是常见的,但严重到足以停药的程度是罕见的。
OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.
评价巴受体激动
临床应疗效性。
Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.
罗匹尼罗是一种类似多巴的多巴
激动
,与第一代多巴
激动
的是没有麦角林结构。罗匹尼罗的非麦角林结构可以说明其与多巴
D2受体有较高的结合力。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦代表本软件的观点;若发现问题,欢迎向我们指正。